Skip to main content

Published locations for Neoadjuvant cisplatin fails to beat standard AC in HER2-negative breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Neoadjuvant cisplatin fails to beat standard AC in HER2-negative breast cancer

User login

  • Reset your password
  • /content/neoadjuvant-cisplatin-fails-beat-standard-ac-her2-negative-breast-cancer
  • /oncologypractice/article/214644/breast-cancer/neoadjuvant-cisplatin-fails-beat-standard-ac-her2
  • /hematology-oncology/article/214644/breast-cancer/neoadjuvant-cisplatin-fails-beat-standard-ac-her2
  • /breast-cancer-icymi/article/214644/breast-cancer/neoadjuvant-cisplatin-fails-beat-standard-ac-her2